Skip to main content

Table 3 Prevalence of youth substance use prior to index admission

From: The CAMP study: feasibility and clinical correlates of standardized assessments of substance use in a youth psychiatric inpatient sample

Substance

Time period or type of use

Total sample (n = 100)

Alcohol

Lifetime

73% (64 to 82)

Past 3 months

51% (41 to 61)

HED past month

29% (20 to 38)

AUDIT 8–15 “risky”a

17 (33% [20 to 46])

AUDIT ≥ 16 “harmful and high risk”a

6 (12% [3 to 21])

Cannabis

Lifetime

66% (57 to 75)

Past 3 months

50% (40 to 60)

Daily past month

18% (10 to 26)

CUDIT 8–11 “hazardous”a

5 (10% [2 to 18])

CUDIT ≥ 12 “possible CUD”a

27 (54% [40 to 68])

Tobacco

Lifetime

47% (37 to 57)

Past 3 months

33% (24 to 42)

Daily past month

14% (7 to 21)

E-cigarettes

Lifetime

42% (32 to 52)

Past 3 months

34% (25 to 43)

Daily past month

14% (7 to 21)

Prescription opioids

Lifetime

22% (14 to 30)

Past 3 months

18% (10 to 26)

Sedatives

Lifetime

22% (14 to 30)

Past 3 months

14% (7 t 21)

Prescription stimulants

Lifetime

21% (13 to 29)

Past 3 months

11% (5 to 17)

Cocaine

Lifetime

18% (10 to 26)

Past 3 months

8% (3 to 13)

Hallucinogens

Lifetime

22% (14 to 30)

Past 3 months

14% (7 to 21)

Solvents

Lifetime

10% (4 to 16)

Past 3 months

4% (0 to 8)

Any prescription drug

Lifetime

35% (26 to 44)

Past 3 months

24% (16 to 32)

Any illicit substance use

Lifetime

34% (25 to 43)

Past 3 months

17% (10 to 24)

Any substance use

Lifetime

79% (71 to 87)

Past 3 months

69% (60 to 78)

  1. Methamphetamines, street opioids, steroids, and synthetic cannabinoids were not included uniquely as prevalence was < 4%
  2. aFor those who endorsed use in the 3 months prior to index visit